Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study.
Bar-Or A, Wiendl H, Montalban X, Alvarez E, Davydovskaya M, Delgado SR, Evdoshenko EP, Giedraitiene N, Gross-Paju K, Haldre S, Herrman CE, Izquierdo G, Karelis G, Leutmezer F, Mares M, Meca-Lallana JE, Mickeviciene D, Nicholas J, Robertson DS, Sazonov DV, Sharlin K, Sundaram B, Totolyan N, Vachova M, Valis M, Bagger M, Häring DA, Ludwig I, Willi R, Zalesak M, Su W, Merschhemke M, Fox EJ. Bar-Or A, et al. Among authors: davydovskaya m. Mult Scler. 2022 May;28(6):910-924. doi: 10.1177/13524585211044479. Epub 2021 Oct 4. Mult Scler. 2022. PMID: 34605319 Free PMC article. Clinical Trial.
COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab.
Cross AH, Delgado S, Habek M, Davydovskaya M, Ward BJ, Cree BAC, Totolyan N, Pingili R, Mancione L, Hu X, Sullivan R, Su W, Zielman R, Gupta AD, Montalban X, Winthrop K. Cross AH, et al. Among authors: davydovskaya m. Neurol Ther. 2022 Jun;11(2):741-758. doi: 10.1007/s40120-022-00341-z. Epub 2022 Mar 13. Neurol Ther. 2022. PMID: 35284994 Free PMC article.
Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab.
Cross AH, Delgado S, Habek M, Davydovskaya M, Ward BJ, Cree BAC, Totolyan N, Pingili R, Mancione L, Hu X, Sullivan R, Su W, Zielman R, Gupta AD, Montalban X, Winthrop K. Cross AH, et al. Among authors: davydovskaya m. Neurol Ther. 2022 Jun;11(2):759-762. doi: 10.1007/s40120-022-00346-8. Neurol Ther. 2022. PMID: 35503396 Free PMC article. No abstract available.
[The efficacy and safety of siponimod in the Russian population of patients with secondary progressive multiple sclerosis].
Evdoshenko EP, Neofidov NA, Bakhtiyarova KZ, Davydovskaya MV, Kairbekova EI, Kolontareva YM, Malkova NA, Odinak MM, Popova EV, Sazonov DV, Stolyarov ID, Smagina IV, Fedyanin AS, Habirov FA, Khaibullin TI, Khachanova NV, Shchukin IA, Boyko AN. Evdoshenko EP, et al. Among authors: davydovskaya mv. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(10. Vyp. 2):110-119. doi: 10.17116/jnevro2019119102110. Zh Nevrol Psikhiatr Im S S Korsakova. 2019. PMID: 31934996 Clinical Trial. Russian.
[Updated recommendations of the Council of Experts on the use and safety of alemtuzumab (Lemtrada)].
Khachanova NV, Bakhtiyarova KZ, Boyko AN, Vlasov YV, Davydovskaya MV, Evdoshenko EP, Zakharova MN, Kotov SV, Popova EV, Sivertseva SA, Totolyan NA, Khabirov FA. Khachanova NV, et al. Among authors: davydovskaya mv. Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(3):82-91. doi: 10.17116/jnevro202012003182. Zh Nevrol Psikhiatr Im S S Korsakova. 2020. PMID: 32323949 Russian.
Real-world study of efficacy, risk management and reasons for discontinuation of natalizumab for treatment of multiple sclerosis in Russia.
Evdoshenko E, Stepanova A, Shumilina M, Davydovskaya M, Khachanova N, Neofidov N, Kalinin I, Popova E, Dubchenko E, Pozhidaeva N, Volkov A, Sivertseva S, Prilenskaya A, Malkova N, Korobko D, Vergunova I, Shchur S, Makshakov G. Evdoshenko E, et al. Among authors: davydovskaya m. PLoS One. 2019 May 28;14(5):e0217303. doi: 10.1371/journal.pone.0217303. eCollection 2019. PLoS One. 2019. PMID: 31136608 Free PMC article.
Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in the Russian Population.
Evdoshenko E, Laskova K, Shumilina M, Nekrashevich E, Andreeva M, Neofidov N, Kalinin I, Nikitchenko D, Rogozina A, Kupaeva A, Bulanov I, Bakirtzis C, Grigoriadis N, Khachanova N, Davydovskaya M, Makshakov G. Evdoshenko E, et al. Among authors: davydovskaya m. J Int Neuropsychol Soc. 2022 May;28(5):503-510. doi: 10.1017/S1355617721000722. Epub 2021 Jun 16. J Int Neuropsychol Soc. 2022. PMID: 34132190
[Recommendations on the algorithms for drug choice and risk management plan in the treatment of patients with remitting multiple sclerosis with natalizumab].
Davydovskaya MV, Khachanova NV, Evdoshenko EP, Pronin IN, Boiko AN, Zakharova MN, Alifirova VM, Turova EA, Malkova NA, Sivertseva SA, Tsukurova LA, Skoromets AA, Solodun IY. Davydovskaya MV, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(10 Pt 2):79-97. doi: 10.17116/jnevro201611610279-97. Zh Nevrol Psikhiatr Im S S Korsakova. 2016. PMID: 28139616 Russian. No abstract available.
[Clinical guidelines for the use of dimethyl fumarate in relapsing-remitting multiple sclerosis].
Alifirova VM, Boiko AN, Vlasov YV, Davydovskaya MV, Zakharova MN, Malkova NA, Popova EV, Sivertseva SA, Spirin NN, Khachanova NV, Shmidt ТЕ. Alifirova VM, et al. Among authors: davydovskaya mv. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(1):97-102. doi: 10.17116/jnevro20171171197-102. Zh Nevrol Psikhiatr Im S S Korsakova. 2017. PMID: 28252608 Russian.
19 results